NCCN
-
October 10, 2020
NCCN Guidelines for Patients: Acute Myeloid Leukemia Bookmark
George Lundberg, MDPDF from the National Comprehensive Cancer Network curated by Contributing Editor George Lundberg, MD, who notes:
The National Comprehensive Cancer Network (NCCN) has issued a 2020 edition of its Guidelines for Patients about acute myeloid leukemia.
Go to full document published by the NCCN.
.
-
October 8, 2020
NCCN Guidelines for Patients: Diffuse Large B-Cell Lymphoma Bookmark
George Lundberg, MDPDF from the National Comprehensive Cancer Network curated by Contributing Editor George Lundberg, MD, who notes:
The National Comprehensive Cancer Network (NCCN) has issued a 2020 edition of its Guidelines for Patients about Diffuse Large B-Cell Lymphoma.
.
-
October 8, 2020
NCCN Guidelines for Patients: Pediatric ALL Bookmark
George Lundberg, MDPDF from the National Comprehensive Cancer Network curated by Contributing Editor George Lundberg, MD, who notes:
The National Comprehensive Cancer Network (NCCN) has issued a 2020 edition of its Guidelines for Patients about Pediatric Acute Lymphoblastic Leukemia.
.
-
October 8, 2020
NCCN Guidelines for Patients: Kidney Cancer Bookmark
George Lundberg, MDPDF from the National Comprehensive Cancer Network curated by Contributing Editor George Lundberg, MD, who notes:
The National Comprehensive Cancer Network (NCCN) has issued a 2020 edition of its Guidelines for Patients about Kidney Cancer.
.
-
October 8, 2020
NCCN Guidelines for Patients: Liver Cancer Bookmark
George Lundberg, MDPDF from the National Comprehensive Cancer Network curated by Contributing Editor George Lundberg, MD, who notes:
The National Comprehensive Cancer Network (NCCN) has issued a 2020 edition of its Guidelines for Patients about Liver Cancer.
.
-
August 15, 2020
NCCN Clinical Practice Guidelines in Oncology: 2020 Updates Bookmark
George Lundberg, MDArticle from The ASCO Post curated by Editor in Chief George Lundberg, MD, who notes:
The National Comprehensive Cancer Network (NCCN) recently made key updates to its clinical practice guidelines. This news story provides a summary of the updates.
Go to full news story published by The ASCO Post.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
March 7, 2019
NCCN 2019 Annual Conference Includes Focus on Patient Experience with Innovative Therapies, Plus Updates on Biomarkers, Biosimilars, and the Latest Research on Cancer Care Bookmark
Emma Shtivelman, PhDExcerpt:
“More than 1,500 cancer care professionals are meeting in Orlando, Florida, March 21-23, for the NCCN 2019 Annual Conference, presented by the National Comprehensive Cancer Network® (NCCN®)—an alliance of 28 leading cancer centers. The conference offers more than 25 sessions presenting the latest treatment recommendations for lung, breast, prostate, colon, and other cancers, including new and emerging therapies. Other key topics include coordination of care, pain management during an opioid crisis, biosimilars, cancer-associated distress, biomarkers, genetic testing, and appropriate transition to end-of-life care. The keynote session highlights the benefits and challenges of treatment with new and innovative therapies (e.g. CAR T-cell) from the perspective of the patient and the clinicians caring for them.”
Go to full article published by the National Comprehensive Cancer Network on Mar 4, 2019.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.